1. Albrightson-Winslow CR, Brickson B, King A, Olivera D, Short B, Saunders C, Badger AM. Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. J Pharm Exp Ther 1990; 255: 382–387.
2. Albrightson CR, Bugelski PJ, Berkhout TA, Jackson B, Kerns WD, Organ AJ, Badger AM. Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranes. J Pharm Exp Ther 1995; 689–698.
3. Badger AM. Discovery and development of the immunomodulatory azaspiranes. In: VJ Merluzzi and J Adams Eds. The Search for Anti-Inflammatory Drugs: Case Histories from concept to clinic, Birkhauser, 1995; 275–301.
4. Badger AM, Kupiec-Weglinski JW. Azaspiranes with therapeutic activity in animal models of autoimmune disease and organ transplantation. In: New Immunosuppressive Modalities in Organ Transplantation, 1994; 93–105.
5. Badger AM, Wright CS. SK&F 106615. Drugs of the Future 1995; 20: 893–896.